4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000271
Director sold 16,000 shares at $75.10 ($1,201,669)
- Director acquired 16,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
LOSCALZO JOSEPH · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-10-31 | Exercise or conversion : show line 1 in the form 10b5-1 | +16,000 | $52.22 | $835,520 | 52,330 | D |
| 2025-10-31 | Sale : show line 2 in the form 10b5-1 | −16,000 | $75.10 | $1,201,669 | 36,330 | D |
| Open-market sales · 16,000 sh · avg $75.10 · $1,201,669 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-10-31 | Exercise or conversion : show line 3 in the form 10b5-1 Non-Qualified Stock Option (right to buy) | −16,000 | 0 | D |
Loading xslF345X05/edgardoc.xml…